Literature DB >> 9684879

Increased caveolin-3 levels in mdx mouse muscles.

P L Vaghy1, J Fang, W Wu, L P Vaghy.   

Abstract

The density of skeletal muscle caveolae is increased in Duchenne muscular dystrophy and its genetic homologue, the mdx mouse. This structural change is significant as it may indicate muscle regeneration. We identified in mdx mouse tibialis anterior muscles significantly increased levels of caveolin-3, the chief protein in muscle caveolae, and reduced levels of neuronal nitric oxide synthase, an enzyme regulated by caveolin-3. Similar changes occurred in the corresponding mRNA levels. These data suggest that induction of caveolin-3 occurs and this may at least partly be responsible for increased number of caveolae, altered nNOS-caveolin cycle, and regeneration of dystrophic muscles.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9684879     DOI: 10.1016/s0014-5793(98)00738-8

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  27 in total

Review 1.  Understanding dystrophinopathies: an inventory of the structural and functional consequences of the absence of dystrophin in muscles of the mdx mouse.

Authors:  J M Gillis
Journal:  J Muscle Res Cell Motil       Date:  1999-10       Impact factor: 2.698

Review 2.  Delineating the role of alterations in lipid metabolism to the pathogenesis of inherited skeletal and cardiac muscle disorders: Thematic Review Series: Genetics of Human Lipid Diseases.

Authors:  Harjot K Saini-Chohan; Ryan W Mitchell; Frédéric M Vaz; Teresa Zelinski; Grant M Hatch
Journal:  J Lipid Res       Date:  2011-11-07       Impact factor: 5.922

3.  Mechanosensitive channel properties and membrane mechanics in mouse dystrophic myotubes.

Authors:  Thomas M Suchyna; Frederick Sachs
Journal:  J Physiol       Date:  2007-01-25       Impact factor: 5.182

4.  Sarcolipin overexpression impairs myogenic differentiation in Duchenne muscular dystrophy.

Authors:  Nandita Niranjan; Satvik Mareedu; Yimin Tian; Kasun Kodippili; Nadezhda Fefelova; Antanina Voit; Lai-Hua Xie; Dongsheng Duan; Gopal J Babu
Journal:  Am J Physiol Cell Physiol       Date:  2019-07-31       Impact factor: 4.249

5.  Modulation of myoblast fusion by caveolin-3 in dystrophic skeletal muscle cells: implications for Duchenne muscular dystrophy and limb-girdle muscular dystrophy-1C.

Authors:  Daniela Volonte; Aaron J Peoples; Ferruccio Galbiati
Journal:  Mol Biol Cell       Date:  2003-08-07       Impact factor: 4.138

Review 6.  Caveolin: a key target for modulating nitric oxide availability in health and disease.

Authors:  Bikramjit Dhillon; Mitesh V Badiwala; Shu-Hong Li; Ren-Ke Li; Richard D Weisel; Donald A G Mickle; Paul W M Fedak; Vivek Rao; Subodh Verma
Journal:  Mol Cell Biochem       Date:  2003-05       Impact factor: 3.396

7.  Matrix metalloproteinase-9 inhibition ameliorates pathogenesis and improves skeletal muscle regeneration in muscular dystrophy.

Authors:  Hong Li; Ashwani Mittal; Denys Y Makonchuk; Shephali Bhatnagar; Ashok Kumar
Journal:  Hum Mol Genet       Date:  2009-04-28       Impact factor: 6.150

8.  Muscular dystrophy begins early in embryonic development deriving from stem cell loss and disrupted skeletal muscle formation.

Authors:  Deborah Merrick; Lukas Kurt Josef Stadler; Dean Larner; Janet Smith
Journal:  Dis Model Mech       Date:  2009-06-17       Impact factor: 5.758

9.  Lipogenesis mitigates dysregulated sarcoplasmic reticulum calcium uptake in muscular dystrophy.

Authors:  Christopher W Paran; Kai Zou; Patrick J Ferrara; Haowei Song; John Turk; Katsuhiko Funai
Journal:  Biochim Biophys Acta       Date:  2015-09-08

10.  Amelioration of muscular dystrophy by transgenic expression of Niemann-Pick C1.

Authors:  Michelle S Steen; Marvin E Adams; Yan Tesch; Stanley C Froehner
Journal:  Mol Biol Cell       Date:  2008-10-22       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.